(Q35262406)

7 August 2017

Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba (English)

1 reference

Erratum: Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba

7 August 2017

corrigendum / erratum

0 references

author name string

C L Baunemann Ott

1

1 reference

7 August 2017

N Ratna

2

1 reference

7 August 2017

R Prayag

3

1 reference

7 August 2017

Z Nugent

4

1 reference

7 August 2017

K Badiani

5

1 reference

7 August 2017

S Navaratnam

6

1 reference

7 August 2017

1 October 2011

1 reference

7 August 2017

1 reference

7 August 2017

18

1 reference

7 August 2017

5

1 reference

7 August 2017

e238-42

1 reference

Creative Commons Attribution 4.0 International

7 August 2017

start time

1 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Population-based patterns and cost of management of metastatic non-small cell lung cancer after completion of chemotherapy until death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Global cancer statistics, 2002

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Chemotherapy for elderly patients with advanced non-small-cell lung cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3185905

Who gets chemotherapy for metastatic lung cancer?

26 September 2018

1 reference

12 December 2020

Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Population variations in the initial treatment of non-small-cell lung cancer

1 reference

12 December 2020

Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.3747/CO.V18I5.780

1 reference

7 August 2017

1 reference

7 August 2017

1 reference